JNJ

J&J depression drug Spravato gets half-hearted backing from VA doctors despite Trump's zeal
J&J depression drug Spravato gets half-hearted backing from VA doctors despite Trump's zeal
Fierce Pharma
JNJ
Spravato
Veteran's Affairs
Donald Trump
depression
Flag link:
Cost-effectiveness watchdogs skewer Novartis' MS drug Mayzent and J&J's depression spray Spravato
Cost-effectiveness watchdogs skewer Novartis' MS drug Mayzent and J&J's depression spray Spravato
Fierce Pharma
Novartis
Mayzent
JNJ
Spravato
ICER
Flag link:
J&J's Ethicon and Spain's Grifols Release 1st Product Out of 10-Year Collaboration Deal
J&J's Ethicon and Spain's Grifols Release 1st Product Out of 10-Year Collaboration Deal
BioSpace
JNJ
Ethicon
Grifols
Vistaseal
surgical bleeding
Flag link:
Janssen’s guselkumab succeeds in phase 3 psoriatic arthritis trials
Janssen’s guselkumab succeeds in phase 3 psoriatic arthritis trials
Pharmaceutical Business Review
JNJ
Janssen
Tremfya
clinical trials
psoriatic arthritis
Flag link:
Janssen Eyes Another Approval for Tremfya After Hitting Trial Endpoints
Janssen Eyes Another Approval for Tremfya After Hitting Trial Endpoints
BioSpace
JNJ
Janssen
clinical trials
Tremfya
psoriatic arthritis
Flag link:
Johnson & Johnson takes a $4.8M hit in talc case, but once again pledges to appeal
Johnson & Johnson takes a $4.8M hit in talc case, but once again pledges to appeal
Fierce Pharma
JNJ
Flag link:
J&J gains an enthusiastic endorsement from President Donald Trump for their big new drug Spravato
J&J gains an enthusiastic endorsement from President Donald Trump for their big new drug Spravato
Endpoints
Donald Trump
JNJ
Spravato
depression
veterans
Flag link:
Fresh analysis spotlights cardio benefit of J&J's Invokana in diabetes patients without history of CV disease
Fresh analysis spotlights cardio benefit of J&J's Invokana in diabetes patients without history of CV disease
Endpoints
JNJ
Invokana
ADA
diabetes
cardiovascular disease
Flag link:
Here's Why Arrowhead Pharmaceuticals Surged 31.9% in May
Here's Why Arrowhead Pharmaceuticals Surged 31.9% in May
Motley Fool
Arrowhead Pharmaceuticals
clinical trials
JNJ
hepatitis B
Flag link:
J&J bags $150M option on Genmab's Darzalex successor
J&J bags $150M option on Genmab's Darzalex successor
Fierce Biotech
Genmab
JNJ
Darzalex
Multiple Myeloma
drug development
Flag link:
Janssen inks nference AI research pact
Janssen inks nference AI research pact
Fierce Biotech
JNJ
Janssen
R&D
artificial intelligence
nference
Flag link:
ASCO: J&J eyes Darzalex convenience, safety boost with subcutaneous win
ASCO: J&J eyes Darzalex convenience, safety boost with subcutaneous win
Fierce Pharma
JNJ
Darzalex
ASCO 2019
Flag link:
ASCO 2019 day one
ASCO 2019 day one
Pharmaforum
ASCO 2019
JNJ
Erleada
AstraZeneca
Merck
Lynparza
prostate cancer
Flag link:
J&J passes key milestone in HIV vaccine trial
J&J passes key milestone in HIV vaccine trial
Pharmaforum
JNJ
Janssen
clinical trials
vaccines
HIV
Imbokodo
Flag link:
Why did Teva ink an $85M deal to sidestep the Oklahoma opioid trial?
Why did Teva ink an $85M deal to sidestep the Oklahoma opioid trial?
Fierce Pharma
Teva Pharmaceutical
JNJ
opioids
Oklahoma
Flag link:
Study Finds Ketamine Nasal Spray Effective For Treating Depression: What You Should Know
Study Finds Ketamine Nasal Spray Effective For Treating Depression: What You Should Know
Forbes
depression
ketamine
esketamine
Spravato
JNJ
Janssen
Flag link:
J&J’s Invokana closes on diabetic kidney disease approval
J&J’s Invokana closes on diabetic kidney disease approval
Pharmaforum
FDA
JNJ
Invokana
diabetic kidney disease
kidney disease
priority review
Flag link:
Jury Orders J&J to Pay Woman $80M in Vaginal Mesh Case
Jury Orders J&J to Pay Woman $80M in Vaginal Mesh Case
Medical Devices and Diagnostics Industry
JNJ
devices
Ethicon
pelvic mesh
Flag link:
Baltimore sues J&J for spinning up a 'sham' Zytiga patent to fend off generics
Baltimore sues J&J for spinning up a 'sham' Zytiga patent to fend off generics
Fierce Pharma
JNJ
Zytiga
generics
competition
Baltimore
Flag link:
6 Things Johnson & Johnson Wants You to Know About Its Pharmaceuticals
6 Things Johnson & Johnson Wants You to Know About Its Pharmaceuticals
Motley Fool
JNJ
devices
Remicade
consumer health
immuno-oncology
Flag link:

Pages